Erythropoietin
- Generic Name
- Erythropoietin
- Brand Names
- Procrit, Eprex, Epprex, Epoetin Alfa Hexal, Silapo, Biopoin, Abseamed, Eporatio, NeoRecormon, Epogen, Retacrit
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 11096-26-7
- Unique Ingredient Identifier
- 64FS3BFH5W
- Background
Erythropoietin (EPO) is a growth factor produced in the kidneys that stimulates the production of red blood cells. It works by promoting the division and differentiation of committed erythroid progenitors in the bone marrow . Epoetin alfa (Epoge) was developed by Amgen Inc. in 1983 as the first rhEPO commercialized in the United States, followed by other alf...
- Indication
用于肾功能不全合并的贫血，艾滋病本身或因治疗引起的贫血，恶性肿瘤伴发的贫血及风湿性贫血等。另外，为择期手术储存自体血而反复采血的患者，同时应用本品可预防发生贫血。
- Associated Conditions
- Anemia, Blood Loss During Surgery, Anemia caused by Zidovudine
- Associated Therapies
- -
Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy
- Conditions
- Interventions
- First Posted Date
- 2017-05-23
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 40
- Registration Number
- NCT03163589
Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya
- Conditions
- Interventions
- First Posted Date
- 2017-05-22
- Last Posted Date
- 2017-06-20
- Lead Sponsor
- Ajou University School of Medicine
- Target Recruit Count
- 37
- Registration Number
- NCT03162588
- Locations
- 🇰🇷
Ajou University Medical Center, Suwon, Gyunggido, Korea, Republic of
Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome
- First Posted Date
- 2017-04-12
- Last Posted Date
- 2017-10-02
- Target Recruit Count
- 400
- Registration Number
- NCT03110341
- Locations
- 🇨🇳
First Affiliated Hospital of Xian JiaotongUniversity, Xi'an, Shaanxi, China
The Effect of Human Recombinant Erythropoietin in Acute Renal Failure
- First Posted Date
- 2017-04-05
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- North Texas Veterans Healthcare System
- Target Recruit Count
- 25
- Registration Number
- NCT03102021
- Locations
- 🇺🇸
Dallas VAMC, Dallas, Texas, United States
Long Term Effects of Erythropoietin in Patients With Moderate to Severe Traumatic Brain Injury
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2023-10-03
- Target Recruit Count
- 356
- Registration Number
- NCT03061565
- Locations
- 🇦🇺
Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia
Proliferative Effects of Erythropoietin on Human Endometrium
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2018-01-23
- Target Recruit Count
- 14
- Registration Number
- NCT03060603
- Locations
- 🇹🇷
Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Atasehir, Turkey
Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation
- Conditions
- Interventions
- First Posted Date
- 2017-01-05
- Last Posted Date
- 2017-01-05
- Lead Sponsor
- Peking University
- Target Recruit Count
- 70
- Registration Number
- NCT03010579
- Locations
- 🇨🇳
Peking University Cancer Hospital & Institute, Beijing, Beijing, China
The Prevention of Erythropoietin on Cardiac Surgery-associated Acute Kidney Injury
- Conditions
- Interventions
- First Posted Date
- 2017-01-02
- Last Posted Date
- 2023-01-26
- Target Recruit Count
- 101
- Registration Number
- NCT03007537
- Locations
- 🇨🇳
Nanjing First Hospital, Nanjing, Jiangsu, China
Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients
- First Posted Date
- 2016-12-28
- Last Posted Date
- 2021-09-29
- Lead Sponsor
- Seoul National University Hospital
- Registration Number
- NCT03004209
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Erythropoietin Effect on Ischemic_ Reperfusion Injury in Coronary Artery Bypass Graft Surgery
- Conditions
- Interventions
- First Posted Date
- 2016-12-06
- Last Posted Date
- 2017-10-24
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 97
- Registration Number
- NCT02984111
- Locations
- 🇮🇷
Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences., Tehran, Iran, Islamic Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.